NUCLEOLIN and cancer: Aptamer-guided delivery systems have been widely investigated for cancer therapy; for example, nucleolin-targeting aptamer AS1411 has been conjugated to NPs carrying chemotherapeutic agents to improve uptake in nucleolin-overexpressing cancer cells [141].